+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Immunotherapy"

CAR T-cell Therapy - Global Strategic Business Report - Product Thumbnail Image

CAR T-cell Therapy - Global Strategic Business Report

  • Report
  • October 2026
  • 179 Pages
  • Global
From
Cancer Therapies - Global Strategic Business Report - Product Thumbnail Image

Cancer Therapies - Global Strategic Business Report

  • Report
  • October 2026
  • 590 Pages
  • Global
From
Esophageal Cancer Drugs - Global Strategic Business Report - Product Thumbnail Image

Esophageal Cancer Drugs - Global Strategic Business Report

  • Report
  • October 2026
  • 269 Pages
  • Global
From
Nasal Corticosteroids - Global Strategic Business Report - Product Thumbnail Image

Nasal Corticosteroids - Global Strategic Business Report

  • Report
  • October 2026
  • 469 Pages
  • Global
From
From
Cancer Immunotherapy - Global Strategic Business Report - Product Thumbnail Image

Cancer Immunotherapy - Global Strategic Business Report

  • Report
  • October 2026
  • 291 Pages
  • Global
From
Antineoplastic Agents - Global Strategic Business Report - Product Thumbnail Image

Antineoplastic Agents - Global Strategic Business Report

  • Report
  • October 2026
  • 183 Pages
  • Global
From
Allergy Vaccines - Global Strategic Business Report - Product Thumbnail Image

Allergy Vaccines - Global Strategic Business Report

  • Report
  • October 2026
  • 481 Pages
  • Global
From
From
Ewing Sarcoma - Global Strategic Business Report - Product Thumbnail Image

Ewing Sarcoma - Global Strategic Business Report

  • Report
  • October 2026
  • 377 Pages
  • Global
From
Sarcoma Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Sarcoma Therapeutics - Global Strategic Business Report

  • Report
  • October 2026
  • 180 Pages
  • Global
From
From
Epithelioma Treatment - Global Strategic Business Report - Product Thumbnail Image

Epithelioma Treatment - Global Strategic Business Report

  • Report
  • October 2026
  • 380 Pages
  • Global
From
Liver Cancer Drugs - Global Strategic Business Report - Product Thumbnail Image

Liver Cancer Drugs - Global Strategic Business Report

  • Report
  • October 2026
  • 391 Pages
  • Global
From
Blood Cancer Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Blood Cancer Therapeutics - Global Strategic Business Report

  • Report
  • October 2026
  • 291 Pages
  • Global
From
From
Cancer Treatment Facilities - Global Strategic Business Report - Product Thumbnail Image

Cancer Treatment Facilities - Global Strategic Business Report

  • Report
  • October 2026
  • 382 Pages
  • Global
From
PD-1 and PD-L1 Inhibitors - Global Strategic Business Report - Product Thumbnail Image

PD-1 and PD-L1 Inhibitors - Global Strategic Business Report

  • Report
  • October 2026
  • 376 Pages
  • Global
From
Eye Allergy Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Eye Allergy Therapeutics - Global Strategic Business Report

  • Report
  • October 2026
  • 190 Pages
  • Global
From
Cancer Biological Therapy - Global Strategic Business Report - Product Thumbnail Image

Cancer Biological Therapy - Global Strategic Business Report

  • Report
  • October 2026
  • 211 Pages
  • Global
From
Loading Indicator

Immunotherapy is a type of treatment used to treat immune disorders, such as allergies, asthma, and autoimmune diseases. It works by stimulating the body's own immune system to fight off disease-causing agents. Immunotherapy drugs are designed to target specific parts of the immune system, such as T-cells, B-cells, and cytokines. These drugs can be used to treat a variety of conditions, including cancer, HIV/AIDS, and rheumatoid arthritis. Immunotherapy drugs are typically administered through injections, infusions, or oral medications. They can also be used in combination with other treatments, such as chemotherapy or radiation therapy. The goal of immunotherapy is to reduce the severity of symptoms and improve the patient's quality of life. The immunotherapy market is a rapidly growing sector of the pharmaceutical industry. Companies in this market are focused on developing new treatments and therapies to treat immune disorders. Some of the major players in this market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, and Pfizer. Show Less Read more